Legal & General Group PLC Cytek Biosciences, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 313,037 shares of CTKB stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

313,037

Previous 301,691 3.76%

Holding current value

$1.51 Million

Previous $1.67 Million 21.54%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$4.7 - $7.4 $53,326 - $83,960	11,346 Added 3.76%	313,037 $2.03 Million
Q3 2024 Nov 14, 2024	BUY	$4.73 - $6.73 $60,841 - $86,567	12,863 Added 4.45%	301,691 $1.67 Million
Q2 2024 Aug 14, 2024	BUY	$5.3 - $6.91 $6,158 - $8,029	1,162 Added 0.4%	288,828 $1.61 Million
Q1 2024 May 14, 2024	SELL	$6.29 - $9.15 $6,919 - $10,065	-1,100 Reduced 0.38%	287,666 $1.93 Million
Q4 2023 Feb 15, 2024	BUY	$4.1 - $9.51 $39,585 - $91,819	9,655 Added 3.46%	288,766 $2.63 Million
Q3 2023 Nov 14, 2023	BUY	$5.52 - $9.5 $262,376 - $451,554	47,532 Added 20.53%	279,111 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $1.3 Million - $2.33 Million	194,270 Added 520.71%	231,579 $1.98 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $12,060 - $19,248	1,429 Added 3.98%	37,309 $342,000
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $4,126 - $6,740	425 Added 1.2%	35,880 $366,000
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $46,021 - $64,874	-4,199 Reduced 10.59%	35,455 $522,000
Q2 2022 Aug 22, 2022	BUY	$7.41 - $11.56 $220,832 - $344,511	29,802 Added 302.5%	39,654 $425,000
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $81,612 - $142,347	8,252 Added 515.75%	9,852 $106,000
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $28,032 - $44,688	1,600 New	1,600 $34,000

Others Institutions Holding CTKB

# of Institutions

150

Shares Held

74M

Call Options Held

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $648M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Cytek Biosciences, Inc. Transaction History